DEGENERATION OF UTERINE LEIOMYOMA

DEGENERATION OF UTERINE LEIOMYOMA was reported 21 times

DEGENERATION OF UTERINE LEIOMYOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SODIUM HYALURONATE 1 0.0012
1 ESTAZOLAM 1 0.0005
2 AMIVANTAMAB-VMJW 1 0.0003
3 INDOMETHACIN 2 0.0002
4 ASFOTASE ALFA 1 0.0001
5 CLOTRIMAZOLE TOPICAL 1 0.0001
6 CLOTRIMAZOLE 1 0.0001
7 GOSERELIN 1 0.0001
8 CALCITRIOL CAPSULES 0.25 MCG 1 0.0000
9 ETONOGESTREL AND ETHINYL ESTRADIOL 1 0.0000
10 ASCORBIC ACID 1 0.0000
11 LINACLOTIDE 1 0.0000
12 RIBOCICLIB 1 0.0000
13 ALENDRONATE SODIUM 3 0.0000
14 LEUPROLIDE ACETATE 2 0.0000
15 COPPER 1 0.0000
16 DROSPIRENONE AND ETHINYL ESTRADIOL 1 0.0000
17 CONJUGATED ESTROGENS 1 0.0000
18 ESTROGENS, CONJUGATED 1 0.0000
19 LEVOFLOXACIN 1 0.0000
20 PANTOPRAZOLE SODIUM INJECTION 1 0.0000
21 VALACYCLOVIR HYDROCHLORIDE 1 0.0000
22 LEVOTHYROXINE SODIUM 4 0.0000
23 METOCLOPRAMIDE HYDROCHLORIDE 1 0.0000
24 ORAL SEMAGLUTIDE 1 0.0000
25 LEVOTHYROXINE SODIUM ANHYDROUS 1 0.0000
26 FOLIC ACID 2 0.0000
27 FLUOXETINE HYDROCHLORIDE 1 0.0000
28 PANTOPRAZOLE SODIUM 1 0.0000
29 LEVONORGESTREL 1 0.0000
30 DENOSUMAB 1 0.0000
31 SIMVASTATIN 1 0.0000
32 PANTOPRAZOLE 1 0.0000
33 ALBUTEROL SULFATE 1 0.0000